Publications and communications of Geenen, Vincent

Perrier d'Hauterive, S., Close, R., Gridelet, V., Mawet, M., Nisolle, M., & Geenen, V. (25 January 2022). Human Chorionic Gonadotropin and Early Embryogenesis: Review. International Journal of Molecular Sciences, 23, 1380. doi:10.3390/ijms23031380

Halouani, A., Michaux, H., Jmii, H., Trussart, C., Chahbi, A., Martens, H., Renard, C., Aouni, M., Hober, D., Geenen, V., & Jaïdane, H. (2021). Coxackievirus B4 transplacental infection severely disturbs central tolerogenic mechanisms in the fetal thymus. Microorganisms, 1537. doi:10.3390/microorganisms9071537

Geenen, V. (20 June 2021). Les arbres à croissance lente embellissent bien plus longtemps que les herbes folles. Le Patient, 55.

Alhazmi, A., Nekoua, M.-P., Michaux, H., Sane, F., Halouani, A., Engelmann, I., Alidjinou, E. K., Martens, H., Jaïdane, H., Geenen, V., & Hober, D. (2021). Effect of Coxsackievirus B4 Infection on the Thymus: Elucidating Its Role in the Pathogenesis of Type 1 Diabetes. Microorganisms. doi:10.3390/microorganisms9061177

Michaux, H., Halouani, A., Trussart, C., Jaïdane, H., Martens, H., Geenen, V., & Hober, D. (15 February 2021). Modulation of IGF2 expression in the murine thymus and thymic epithelial cells following coxsackie-B4 infection. Microorganisms, 9 (402), 1-21. doi:10.3390/microorganisms9020402

Geenen, V. (2021). The thymus and the science of Self. Seminars in Immunopathology, 1-10. doi:10.1007/s00281-020-00831-y

VALDES SOCIN, H. G., Gonzales-Aguilera, B., & Geenen, V. (2020). Letter to the Editor from Hernan Valdes-Socin: “Genetic Study in a Large Cohort Supported Different Pathogenesis of Graves’ Disease and Hashimoto’s Hypothyroidism”. Journal of Clinical Endocrinology and Metabolism. doi:10.1210/clinem/dgaa456

Geenen, V., Martens, H., RENARD, J. D. C., & Trussart, C. (02 April 2020). A unifying model of self-tolerance and autoimmunity to the neuroendocrine system. Paper presented at 5th International Multidisciplinary Medical Congress, Tirana, Albania.

Halouani, A., Jmii, H., Bodart, G., Michaux, H., Renard, C., Martens, H., Aouni, M., Hober, D., Geenen, V., & Jaïdane, H. (02 April 2020). Assessment of thymic output dynamics after in utero infection of mice with coxsakievirus B4. Frontiers in Immunology, 11, 481. doi:10.3389/fimmu.2020.00481

Gridelet, V., PERRIER d'HAUTERIVE, S., Polese, B., Foidart, J.-M., Nisolle, M., & Geenen, V. (11 March 2020). Human chorionic gonadotrophin (hCG): new pleiotropic functions for an "old" hormone during pregnancy. Frontiers in Immunology, 11, 343. doi:10.3389/fimmu.2020.00343

Halouani, A., Jmii, H., Michaux, H., RENARD, J. D. C., Martens, H., Pirottin, D., Mastouri, M., Aouni, M., Geenen, V., & Jaïdane, H. (03 March 2020). Housekeeping Gene Expression in the Fetal and Neonatal Murine Thymus Following Coxsackievirus B4 Infection. Genes, 11, 279. doi:10.3390/genes11030279

Geenen, V. (12 February 2020). L'influence de Charles Darwin sur la biologie aujourd'hui. Paper presented at Darwin Day 2020, Liège, Belgium.

Geenen, V. (21 January 2020). L'Héritage[s] de Charles Darwin. Paper presented at Forum des Savoirs de l'ULiège, Liège, Belgium.

Geenen, V. (16 December 2019). Le clonage : quelles limites aujourd'hui et demain ? Paper presented at Conférence du service d'Ophtalmologie du CHU de Liège, Liège Colonster, Belgium.

Geenen, V. (2019). A grateful tribute to Professor Helen KORNEVA. In Homage Book to Helen Korneva. University of St Petersburg.

Geenen, V., & Hober, D. (December 2019). Programing of the autoimmune diabetogenic response in the thymus during fetal and perinatal life. Pediatric Endocrinology Reviews, 17, 35-40. doi:10.17458/per.vol17.2019.gh.fd.autoimmunediabetogenicthymus

Geenen, V. (29 November 2019). "Petits" inconvénients de l'immunothérapie anti-tumorale. Paper presented at Enseignement de formation continue de l'AMLg, Liège, Belgium.

Geenen, V. (2019). Vers un nouveau type de vaccin contre le diabète de type 1 ? (ULiège - Université de Liège). Bruxelles, Belgium: ABD.

Geenen, V. (2019). Vers un vaccin belge contre le diabète ? Le Vif. L'Express.

Daniel, S., LOMMERS, E., HANSEN, I., DIVE, D., GEENEN, V., Beckers, A., & VALDES SOCIN, H. G. (2019). Thyroid dysfunction after Alemtuzumab treatment for multiple sclerosis : diagnostic and therapeutic modalities. In Endocrine Abstracts - ECE 2019.

Geenen, V. (2019). La longue et fascinante épopée de la vaccination. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/234747.

Geenen, V., Trussart, C., Michaux, H., Halouani, A., Jaïdane, H., RENARD, J. D. C., Collée, C., Daukandt, M., Ledent, P., & Martens, H. (2019). The presentation of neuroendocrine self-peptides in the thymus: An essential event for individual life and vertebrate survival. Annals of the New York Academy of Sciences. doi:10.1111/nyas.14089

Geenen, V. (2019). Les géants de la science en Outremeuse.

Geenen, V. (2019). La Seconde Guerre Mondiale - La science biomédicale qui sauve. Paper presented at Espace Universitaire 2018-2019, Liège, Belgium.

Parent, A.-S., Zoeller, R. T., Geenen, V., Demeneix, B., Skakkebaek, N. E., & Santen, R. J. (2019). Remembering Jean-Pierre Bourguignon, MD, PhD. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/233788.

Daniel, S., HANSEN, I., Dive, D., Geenen, V., Beckers, A., & VALDES SOCIN, H. G. (December 2018). Thyroid dysfunction after Alemtuzumab treatment for multiple sclerosis : a report of four cases. Acta Clinica Belgica, 73 (2).

Farhat, K., Bodart, G., Moutschen, M., Salvatori, R., Martens, H., & Geenen, V. (December 2018). Growth hormone (GH) deficient mice with GHRH ablation are severely deficient in vaccine and immune responses against Streptococcus pneumoniae. Acta Clinica Belgica, 73 (6 (Suppl.2)).

Geenen, V. (2018). De la tolérance à l'auto-immunité : l'exemple du diabète de type 1. Paper presented at Cours de l'Espace Universitaire de Liège - Module sciences de la santé, Liège, Belgium.

Farhat, K., Bodart, G., Charlet-Renard, J. D. C., Desmet, C., Moutschen, M., Beguin, Y., Baron, F., Melin, P., Quatresooz, P., Parent, A.-S., Desmecht, D., Sirard, J.-C., Salvatori, R., Martens, H., & Geenen, V. (02 October 2018). Growth hormone (GH) deficient mice with GHRH ablation are severely deficient in vaccine and immune responses against Streptococcus pneumoniae. Frontiers in Immunology, 9, 2175. doi:10.3389/fimmu.2018.02175

Geenen, V., & Martens, H. (September 2018). Historical introduction to the history of the thymus and the concept of immune self-tolerance. Paper presented at 22nd Internnational Symposium on Regulatory Peptides (RegPep2018), Acapulco, Mexico.

VALDES SOCIN, H. G., HARVENGT, J., Pintiaux, A., JONAS, C., PARENT, A.-S., Geenen, V., CORMAN, V., DEBRAY, F.-G., Dideberg, V., T'sjoen, G., De Leerner, A., Beckers, D., Destree, A., Roland, D., Lederer, D., Boscolo, M., Burlacu, C., VROONEN, L., Bours, V., & Beckers, A. (September 2018). Etude multicentrique belge chez 56 patients avec hypogonadisme hypogonadotrope congénital (HHC) : caractérisation des anomalies génétiques et cérébrales. Poster session presented at 35ème Congrès de la Société Française d'Endocrinologie, Nancy, France.

Bodart, G., Farhat, K., Charlet-Renard, J. D. C., Becker, G., Plenevaux, A., Salvatori, R., Geenen, V., & Martens, H. (06 June 2018). The severe deficiency of the somatotrope GHRH/GH/IGF1 axis of Ghrh-/- mice is associated with an important splenic atrophy and relative B lymphopenia. Frontiers in Endocrinology, 9 (Art. 296). doi:10.3389/fendo.2018.00296

Geenen, V. (2018). Les progrès en immunologie sont à la base des plus grands succès médicaux. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/235602.

VALDES SOCIN, H. G., LIBIOULLE, C., HARVENGT, J., PINTIAUX, A., JONAS, C., Parent, A.-S., GEENEN, V., CORMAN, V., Debray, F.-G., DIDEBERG, V., T'Sjoen, G., De Leerner, A., Beckers, D., Destree, A., Roland, D., Lederer, D., Boscolo, M., Bours, V., Maiter, D., & Beckers, A. (May 2018). The first Belgian series of 56 patients with congenital hypogonadotropic hypogonadism (CHH) : genetics and brain abnormalities. Poster session presented at 20th European Congress of Endocrinology.

VALDES SOCIN, H. G., LIBIOULLE, C., HARVENGT, J., Pintiaux, A., JONAS, C., PARENT, A.-S., GEENEN, V., CORMAN, V., Debray, F.-G., DIDEBERG, V., T'Sjoen, G., De Leerner, A., Beckers, D., Destree, A., Roland, D., Lederer, D., Boscolo, M., BOURS, V., Maiter, D., & BECKERS, A. (2018). Brain imaging and genetics in patients with congenital hypogonadotropic hypogonadism: a multicenter Belgian study. In J. O. Jorgensen, NENEG Abstract Book Communications (pp. 64). Aarhus, Denmark: Pfizer.

Geenen, V. (28 February 2018). Le thymus, d'un vestige de l'évolution à un organe essentiel pour la survie de l'individu et de l'espèce. Paper presented at Collège Belgique - Cours "Tout ce que vous devez savoir sur le thymus sans avoir jamais osé le demander, Bruxelles, Belgium.

Geenen, V. (08 February 2018). De la métaphore créative à l'innovation thérapeutique. Paper presented at Liège Créative, Liège, Belgium.

Polese, B., Gridelet, V., Perrier d'Hauterive, S., Charlet-Renard, J. D. C., Munaut, C., Martens, H., Vermijlen, D., King, I. L., Jacobs, N., & Geenen, V. (29 January 2018). Accumulation of IL-17+ Vgamma6+ gamma-delta T cells in pregnant mice is not associated with spontaneous abortion. Clinical and Translational Immunology, 7, 1008. doi:10.1002/cti2.1008

Amorim, C., Andris, F., Arckens, L., Arnould, T., Aron, S., Bakker, J., Balligand, M., Balthazart, J., Baron, F., Beck, B., Beguin, Y., Behets, C., Bellefroid, E., Bertrand, L., Bettendorff, L., Bindels, L., Blankert, B., Blanpain, C., Bondue, A., & Wittamer, V. (2017). L’expérimentation animale reste indispensable (OPINION). La Libre Belgique.

Geenen, V. (13 November 2017). The Physiology of The Thymus. Paper presented at Course in Biomedical sciences, Maastricht, Netherlands.

Geenen, V. (25 October 2017). Processus cognitifs communs aux créativités scientifique et artistique. Paper presented at Art et science : regards croisés, Liège, Belgium.

DE VOEGHT, A., Martens, H., RENARD, J. D. C., VAIRA, D., Debruche, M., Simonet, J., Geenen, V., MOUTSCHEN, M., & DARCIS, G. (2017). Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium. PLoS ONE. doi:10.1371/journal.pone.0185761

Geenen, V. (17 October 2017). Development of a negative self-vaccine against type 1 diabetes based on central tolerogenic properties of the thymus. Paper presented at Flanders vaccines & BioWin, Ghent, Belgium.

Geenen, V. (June 2017). Histoire du thymus : d'un organe vestigial à la programmation de la tolérance immunitaire. MS. Medecine Sciences, 33 (6-7), 634-644. doi:10.1051/medsci/20173306024

Moreno-Reyes, R., Bex, M., Corvilain, B., Daumerie, C., Decallonne, B., GEENEN, V., Gruson, D., Lapauw, B., Poppe, K., & Van den Bruel, A. (2017). World Thyroid Day 2017 - Press annoucement. Commentary.

Farhat, K., Bodart, G., RENARD, J. D. C., Desmet, C., MOUTSCHEN, M., Beguin, Y., Baron, F., Salvatori, R., Geenen, V., & Martens, H. (23 May 2017). A surprising and dramatic neuroendocrine-immune phenotype of mice deficient in Growth Hormone-Releasing Hormone (GHRH). Poster session presented at European Congress of Endocrinology, Lisbonne, Portugal. doi:10.1530/endoabs.49.EP883

Geenen, V. (2017). Y a-t-il une limite à la longévité de l'Homme ? L'Homme peut-il être immortel ? Paper presented at Cycles de cours de l'ULiège à Verviers, Verviers, Belgium.

Farhat, K., Bodart, G., Renard, C., Desmet, C., MOUTSCHEN, M., BARON, F., Beguin, Y., Salvatori, R., Martens, H., & GEENEN, V. (May 2017). A surprising and dramatic neuroendocrine-immune phenotype of mice deficient in Growth Hormone-Releasing Hormone (GHRH). Poster session presented at The 19th European Congress of Endocrinology, Lisbon, Portugal.

Luong, J., & GEENEN, V. (2017). Le boom des maladies auto-immunes. Femmes d'aujourd'hui, p. 29-30.

Michaux, H., Charlet-Renard, C., Martens, H., & Geenen, V. (12 March 2017). Mechanisms of Igf2 inhibition in thymic epithelial cells infected with CVB4 E2. Poster session presented at IGF & Insulin System in Physiology & Disease, Ventura, United States - California.

Geenen, V. (2017). L'ocytocine et la biologie du coup de foudre. Paper presented at Doc'Café, Liège, Belgium.

Geenen, V. (2017). Voyage[s] à travers le thymus. Science et Culture, (465), 14-15.

Geenen, V. (2017). Les écoles liégeoises de physiologie et de médecine aux 19e et 20e siècle. Paper presented at Cycle de cours "Histoire de Liège", Liège, Belgium.

Geenen, V. (2017). L'Homme peut-il devenir immortel ?

Saveri, M., Stefenatto, N., BONHOMME, V., GEENEN, V., & BRICHANT, J.-F. (2017). The role of the oxytocinergic system in pain physiology : new data and possible therapeutic strategies. Acta Anaesthesiologica Belgica, 68 (4), 157-166.

VALDES SOCIN, H. G., DEBRAY, F.-G., LIBIOULLE, C., Pintiaux, A., Parent, A.-S., CORMAN, V., Gellner, K., Geenen, V., VROONEN, L., DIDEBERG, V., Bours, V., & BECKERS, A. (2016). Caractérisation clinique, neuroendocrinienne, génétique et résultats thérapeutiques dans le syndrome de Kallmann et de l'hypogonadisme normosmique idiopathique : expérience liégeoise. In Annales d'Endocrinologie : 33ème congrès de la Société Française d'Endocrinologie.

Daubenbüchel, A., Hoffmann, A., Eveslage, M., Özyurt, J., Lohle, K., Reichel, J., Thiel, C. M., Martens, H., Geenen, V., & Müller, H. L. (2016). Oxytocin in survivors of childhood-onset craniopharyngioma. Endocrine. doi:10.1007/s12020-016-1084-5

Geenen, V. (16 April 2016). Drug-induced thyroid dysfunction. Paper presented at 48th Meeting of the Belgian Thyroid Club, Bruxelles, Belgium.

Geenen, V. (24 March 2016). Thymus and Type 1 diabetes: Where are we now? Paper presented at Conférence invitée, Marseille, Centre d'Immunologie Marseille-Luminy (CIML), France.

VALDES SOCIN, H. G., LIBIOULLE, C., Debray, F.-G., Pintiaux, A., Parent, A.-S., CORMAN, V., Gellner, K., Geenen, V., Burlacu, C., JONAS, C., Maiter, D., T'Sjoen, G., Poppe, K., Brachet, C., DIDEBERG, V., Bours, V., & Beckers, A. (2016). Neuroendocrine phenotype, genetics and hormonal treatment outcome in idiopathic normosmic hypogonadism and Kallman syndrome patients : A multicenter Belgian Study. In Acta Clinical Belgica.

Maiga, I., BETEA, D., Geenen, V., LUYCKX, F., Beckers, A., & VALDES SOCIN, H. G. (2015). Switch from Hashimoto Thyroiditis (HT) to Graves Basedow (GB) disease : a controlled study in a series of 15 patients. In Abstract book - 20th Annual Congress of the Belgian Society of Internal Medicine.

Geenen, V. (June 2015). The central role of the thymus in the programming of immunological tolerance to neuroendocrine self: Implications for the pathogenesis of autoimmune diseases
. Paper presented at International Symposium”Interactions of the nervous and immune systems in health and disease”, Saint Petersburg, Russia.

Geenen, V. (May 2015). L'école liégeoise de physiologie aux 19e et 20e siècles. Histoire des Sciences Médicales, XLIX (2), 209-218.

Bodart, G., Goffinet, L., Morrhaye, G., de Saint-Hubert, M., Debacq-Chainiaux, F., Swine, C., Geenen, V., & Martens, H. (2015). Somatotrope GHRH/GH/IGF-1 axis at the crossroad between immunosenescence and elder frailty. Annals of the New York Academy of Sciences, 1351, 61-67. doi:10.1111/nyas.12857

Geenen, V. (2015). Introduction à l'embryologie animale. (ULiège - Université de Liège, BIOL019-1).

Michaux, H., Martens, H., Jaïdane, H., Halouani, A., Hober, D., & Geenen, V. (2015). How does thymus infection by coxsackievirus contribute to the pathogenesis of type 1 diabetes? Frontiers in Immunology, 6 (Article 338), 1-6. doi:10.3389/fimmu.2015.00338

Scantamburlo, G., Hansenne, M., Geenen, V., Legros, J.-J., & Ansseau, M. (January 2015). Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: An open trial. European Psychiatry, 30 (1), 65-68. doi:10.1016/j.eurpsy.2014.08.007

Alidjinou, E. K., Sané, F., Engelmann, I., Geenen, V., & Hober, D. (November 2014). Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes. Discovery Medicine, 18, 273-282.

Geenen, V. (25 September 2014). 9th Congress of the International Society of NeuroImmunoModulation (ISNIM). Paper presented at 9th Congress of ISNIM, Li§ge, Belgium.

Polese, B., Gridelet, V., Arakioti, E., Martens, H., Perrier d'Hauterive, S., & Geenen, V. (07 July 2014). The endocrine milieu and CD4 T-lymphocyte polarization during pregnancy. Frontiers in Endocrinology, 5 (Article 106), 1-11. doi:10.3389/fendo.2014.00106

Geenen, V. (2014). The thymus in 2013: from a 'vestigial' organ to immunological self-tolerance and autoimmunity. Proceedings of the Belgian Royal Academies of Medicine, 3, 171-193.

Hayez, A., Malaisse, J., Rogiers, E., Reynier, M., RENARD, J. D. C., Haftek, M., Geenen, V., Serre, G., Simon, M., Lambert de Rouvroit, C., Michiels, C., & Poumay, Y. (2014). High TMEM45A expression is correlated to epidermal keratinization. Experimental Dermatology, 23, 339-344. doi:10.1111/exd.12403

Geenen, V. (08 November 2013). New Insights into Thymus Physiology. Paper presented at 2013 Annual Meeting of the Belgian Immunological Society (BIS), Liége, Belgium.

Geenen, V. (26 October 2013). Le thymus en 2013 : d’un organe ‘vestigial’ à la tolérance immunitaire vis-à-vis du Soi et à l’auto-immunité. Paper presented at Académie Royale de Médecine de Belgique (ARMB), Bruxelles, Belgium.

Geenen, V., Bodart, G., Henry, S., Michaux, H., Dardenne, O., RENARD, J. D. C., Martens, H., & Hober, D. (16 October 2013). Programming of neuroendocrine self in the thymus and its defect in neuroendocrine autoimmunity. Frontiers in Neuroscience, 7. doi:10.3389/fnins.2013.00187

Geenen, V. (2013). Le thymus aujourd'hui : d'un organe 'vestigial' à la tolérance au Soi et à l'auto-immunité.

Gridelet, V., Tsampalas, M., Berndt, S., Hagelstein, M.-T., Charlet-Renard, J. D. C., Ectors, F., Hugé, F., Munaut, C., Foidart, J.-M., Geenen, V., & Perrier d'Hauterive, S. (2013). Evidence for cross-talk between the LH receptor and LH during implantation in mice. Reproduction, Fertility and Development, 25, 511-522. doi:10.1071/RD11241

Scantamburlo, G., ANSSEAU, M., Geenen, V., & Legros, J.-J. (2013). AMELIORATION DE L’HUMEUR ET DE L’ANXIETE SOUS OCYTOCINE DANS LA DEPRESSION: ETUDE PILOTE. Encéphale (L').

Geenen, V., Bakker, J., Hoekzema, E., & Scantamburlo, G. (2012). Deregulation of Oxytocin and Vasopressin in Williams Syndrome: A New Model For Exploring Neurogenetics and Neurobiology of Human Social Behavior. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/133427.

Gridelet, V., GASPARD, O., Polese, B., RUGGERI, P., RAVET, S., Munaut, C., Geenen, V., Foidart, J.-M., Ledée, N., & Perrier d'Hauterive, S. (2012). The actors of human implantation: gametes, embryo and endometrium. In L. A. Violin Pereira (Ed.), Embryology - Updates and Highlights on Classic Topics (pp. 5, 85-126). InTech. doi:10.5772/32831

Geenen, V. (2012). The presentation of neuroendocrine self in the thymus: a necessity for an integrated evolution of the immune and neuroendocrine systems. Annals of the New York Academy of Sciences, 1261, 42-48. doi:10.1111/j.1749-6632.2012.06624.x

Geenen, V. (2012). The appearance of the thymus and the integrated evolution of adaptive immune and neuroendocrine systems. Acta Clinica Belgica, 67, 209-213.

Jaïdane, H., Caloone, D., Lobert, P.-E., Sane, F., Dardenne, O., Naquet, P., Gharbi, J., Geenen, V., & Hober, D. (2012). Persistent infection of thymic epithelial cells with coxsackievirus B4 results in a decreased expression of insulin-like growth factor 2. Journal of Virology, 86, 11151-11162. doi:10.1128/JVI.00726-12

Jaïdane, H., Sane, F., Hiar, R., Goffard, A., Gharbi, J., Geenen, V., & Hober, D. (2012). Immunology in the clinic review series. Focus on type 1 diabetes and virus: enterovirus, thymus and type 1 diabetes pathogenesis. Clinical and Experimental Immunology, 168, 39-46. doi:10.1111/j.1365-2249.2011.04558.x

Vermeire, S., Carbonnel, F., Coulie, P., Geenen, V., Hazes, J. M. W., Masson, P., de Keyser, F., & LOUIS, E. (2012). Management of inflammatory bowel disease in pregnancy. Journal of Crohn's and Colitis, 6 (8), 811-23. doi:10.1016/j.crohns.2012.04.009

Chentoufi, A. A., Geenen, V., Giannokakis, N., & Amrani, A. (2011). Editorial. In A. A. Chentoufi, V. Geenen, N. Giannokakis, & A. Amrani (Eds.), Type 1 Diabetes Immunological Tolerance and Immunotherapy. Hindawi. doi:10.1155/2011/103738

Geenen, V. (03 December 2011). Thyroid and the thymus. Paper presented at 39th Meeting of the Belgian Thyroid Club (BTC), Brussels, Belgium.

Geenen, V. (20 October 2011). The presentation of neuroendocrine self in the thymus: a necessity for an integrated evolution of the adaptive immune response and the neuroendocrine system. Neuroimmunomodulation, 18 (6), 375.

Deblon, N., Veyrat-Durebex, C., Bourgoin, L., Caillon, A., Bussier, A.-L., Petrosino, S., Piscitelli, F., Legros, J.-J., Geenen, V., Foti, M., Wahli, W., Di Marzo, V., & Rohner-Jeanrenaud, F. (27 September 2011). Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS ONE, 6, 25565. doi:10.1371/journal.pone.0025565

Geenen, V. (2011). Impact of the thymus emergence on integrated evolution of the adaptative immune and neuroendocrine systems. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/61874.

Geenen, V. (2011). Claude Bernard (1813-1878), the father of modern physiology and experimental medicine. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/79049.

Hazes, J. M. W., Coulie, P. G., Geenen, V., Vermeire, S., Carbonnel, F., LOUIS, E., Masson, P., & De Keyser, F. (2011). Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. Rheumatology. doi:10.1093/rheumatology/ker302

Goffinet, L., Renard-Charlet, C., Martens, H., & Geenen, V. (April 2011). Insulin-like growth factor 1 (IGF-1) promotes interleukin 7 (IL-7) synthesis and secretion by primary cultures of human thymic epithelial cells. Scandinavian Journal of Immunology, 73, 351.

Mottet, M., Martens, H., Renard-Charlet, C., Drion, P., Dardenne, O., & Geenen, V. (2011). Preliminary characterisation of a transgenic mouse with selective Igf2 depletion in the thymic epithelium. Scandinavian Journal of Immunology.

CASTERMANS, E., Hannon, M., Dutrieux, J., Humblet, S., Seidel, L., Cheynier, R., Willems, E., Gothot, A., Vanbellinghen, J.-F., Geenen, V., Sandmaier, B. M., Storb, R., Beguin, Y., & Baron, F. (2011). Thymic recovery after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning is limited to patients younger than 60 years of age. Haematologica, 96(2), 298-306. doi:10.3324/haematol.2010.029702

de Saint-Hubert, M., Jamart, J., Morrhaye, G., Martens, H., Geenen, V., Duy Vo, T. K., Toussaint, O., & Swine, C. (2011). Serum IL-6 and IGF-1 improve clinical prediction of functional decline after hospitalization in older patients. Aging Clinical and Experimental Research, 23, 106-111. doi:10.3275/7028

Goffinet, L., Mottet, M., Kermani, H., Renard-Charlet, J. D. C., Geenen, V., & Martens, H. (2011). Impact of the somatotrope Growth Hormone (GH)/Insulin-like Growth Factor 1 (IGF-1) axis upon thymus function: Pharmacological implications in regeneration of immune functions. Immunology, Endocrine and Metabolic Agents - Medicinal Chemistry, 11, 10-20. doi:10.2174/187152211794519421

TOME GARCIA, M., VALDES SOCIN, H. G., LUTTERI, L., BETEA, D., VROONEN, L., PETROSSIANS, P., Geenen, V., Louis, E., & Beckers, A. (2011). The Thyro-gastric syndrome : its prevalence, clinical, pathological and predictive factors in a prospective series of 360 patients with Hashimoto's Thyroiditis. In Abstract book - 21st Meeting of the Belgian Endocrine Society.

Geenen, V. (June 2010). The thymus as an obligatory intersection between the immune and neuroendocrine systems: pharmacological implications. Current Opinion in Pharmacology, 10. doi:10.1016/j.coph.2010.05.011

Duy Vo, T. K., Godard, P., de Saint-Hubert, M., Morrhaye, G., Bauwens, E., Debacq-Chainiaux, F., Glupczynski, Y., Swine, C., Geenen, V., Martens, H., & Toussaint, O. (2010). Transcriptomic biomarkers of human ageing in peripheral blood mononuclear cell total RNA. Experimental Gerontology, 45, 188-194. doi:10.1016/j.exger.2009.12.001

Duy Vo, T. K., Godard, P., de Saint-Hubert, M., Morrhaye, G., Swine, C., Geenen, V., Martens, H., Debacq-Chainiaux, F., & Toussaint, O. (2010). Transcriptomic biomarkers of the response of hospitalized geriatric patients with infectious diseases. Immunity and Ageing, 17, 7-9. doi:10.1186/1742-4933-7-9

Geenen, V. (2010). Euro-Thymaide - Final publishable report. Brussels, Belgium: European Commission.

Geenen, V. (Ed.). (2010). Current Opinion in Pharmacology, Volume 10, Issue 4, Section Immunomodulation. Current Opinion in Pharmacology, 10 (Issue 4), 405-504.

Geenen, V., Mottet, M., Dardenne, O., Kermani, H., Martens, H., François, J.-M., Galleni, M., Hober, D., Rahmouni, S., & Moutschen, M. (2010). Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes. Current Opinion in Pharmacology, 10, 461-472. doi:10.1016/j.coph.2010.04.005

VALDES SOCIN, H. G., VROONEN, L., Latta, A., BETEA, D., PETROSSIANS, P., Geenen, V., & Beckers, A. (2010). Le tabac et ses effets sur le système endocrinien. Revue Médicale de Liège, 65 (9), 498-501.

Castermans, E., Hannon, M., Cheynier, R., Seidel, L., Humblet-Baron, S., WILLEMS, E., Corbier, S., Gothot, A., Geenen, V., Sandmaier, B. M., Storb, R. F., Beguin, Y., & Baron, F. (2009). Thymic Recovery After Allogeneic Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning Might Be Limited to Patients Younger Than 60 Years of Age. Blood, 114 (22), 1149.

Castermans, E., Hannon, M., Drion, P., Geenen, V., Beguin, Y., & Baron, F. (2009). Reconstitution du système immunitaire après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 64 (S1), 2-8.

Geenen, V., & Dardenne Olivier. (2009). Thymus dysfunction in the development of type 1 diabetes and endocrine autoimmune diseases. European Endocrinology, 5, 24-26.

Hansenne, I., Louis, C., Martens, H., Dorban, G., Renard, C., Peterson, P., & Geenen, V. (2009). Aire and Foxp3 expression in a particular microenvironment for T-cell differentiation. Neuroimmunomodulation, 16, 35-44. doi:10.1159/000179665

Morrhaye, G., Kermani, H., Legros, J.-J., Baron, F., Beguin, Y., Moutschen, M., Cheynier, R., Martens, H., & Geenen, V. (2009). Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients. PLoS ONE, 4 (5), 5668. doi:10.1371/journal.pone.0005668

Brilot, F., Jaidane, H., Geenen, V., & Hober, D. (April 2008). Coxsackievirus B4 Infection of Murine Foetal Thymus Organ Cultures. Journal of Medical Virology, 80 (4), 659-66. doi:10.1002/jmv.21016

Castermans, E.* , Baron, F.* , Willems, E., Schaaf-Lafontaine, N., Meuris, N., Gothot, A., Vanbellinghen, J.-F., Herens, C., Seidel, L., Geenen, V., Cheynier, R., & Beguin, Y. (2008). Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning. Haematologica, 93 (2), 240-7. doi:10.3324/haematol.11708

Geenen, V. (2008). Les cibles hormonales de la réponse auto-immune. Annales d'Endocrinologie, 69, 107-111. doi:10.1016/j.ando.2008.02.006

Geenen, V. (2008). HLA genetics in 'latent' autoimmune diabetes of adults (LADA). International Diabetes Monitor, 20, 144-145.

Geenen, V. (2007). Histoire de la recherche biomédicale. (ULiège - Université de Liège, MEDE0430-1).

Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Baron, F., Beguin, Y., & Geenen, V. (2007). Evaluation clinique de la fonction du thymus. Revue Médicale de Liège, 62 (11), 675-8.

Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Geenen, V., Beguin, Y., & Baron, F. (2007). Evaluation de la thymopoiese: applications cliniques. Revue Médicale de Liège, 62 (12), 725-9.

Geenen, V. (2007). Cellules souches embryonnaires, clonage reproductif, clonage thérapeutique: discussion et discernement bioéthiques. Science and Culture.

Geenen, V. (November 2006). Thymus-dependent T cell tolerance of neuroendocrine functions - Principles, reflections, and implications for tolerogenic/negative self-vaccination. Annals of the New York Academy of Sciences, 1088, 284-296. doi:10.1196/annals.1366.009

Hansenne, I., Renard-Charlet, C., Greimers, R., & Geenen, V. (15 April 2006). Dendritic cell differentiation and immune tolerance to insulin-related peptides in Igf2-deficient mice. Journal of Immunology, 176 (8), 4651-4657. doi:10.4049/jimmunol.176.8.4651

Geenen, V. (2006). Type 1 diabetes susceptibility loci from genome scans in multiplex families. International Diabetes Monitor, 18, 32-33.

Geenen, V. (2006). Antiviral diabetes susceptibility gene. International Diabetes Monitor, 18, 30-31.

Jaidane, H., Gharbi, J., Lobert, P. E., Lucas, B., Hiar, R., Ben M'Hadheb, M., Brilot, F., Geenen, V., Aouni, M., & Hober, D. (2006). Prolonged viral RNA detection in blood and lymphoid tissues from Coxsackievirus B4 E2 orally-inoculated Swiss mice. Microbiology and Immunology, 50 (12), 971-974. doi:10.1111/j.1348-0421.2006.tb03874.x

PERRIER d'HAUTERIVE, S., Charlet-Renard, J. D. C., Dubois, M., Foidart, J.-M., & Geenen, V. (2006). Du nouveau à l'interface materno-foetale: rôle du couple hCG/récepteur LH-hCG dans l'implantation embryonnaire. Revue Médicale de Liège, 61 (10), 705-12.

Pequeux, C., Breton, C., Hagelstein, M. T., Geenen, V., & Legros, J.-J. (November 2005). Oxytocin receptor pattern of expression in primary lung cancer and in normal human lung. Lung Cancer, 50 (2), 177-188. doi:10.1016/j.lungcan.2005.05.027

Brilot, F., & Geenen, V. (2005). Le role des virus dans la pathogenie du diabete de type 1. Revue Médicale de Liège, 60 (5-6, May-Jun), 297-302.

Geenen, V. (2005). Thymus self-antigens as a way for restoring self-tolerance in type 1 diabetes. Journal of NeuroImmunoModulation.

Geenen, V., Brilot, F., Louis, C., Hansenne, I., Renard, C., & Martens, H. (2005). Nouvelles donnees sur la pathogenie du diabete de type 1. Revue Médicale de Liège, 60 (5-6, May-Jun), 291-6.

Hansenne, I., Rasier, G., Pequeux, C., Brilot, F., Renard, C., Breton, C., Greimers, R., Legros, J.-J., Geenen, V., & Martens, H. J. (January 2005). Ontogenesis and functional aspects of oxytocin and vasopressin gene expression in the thymus network. Journal of Neuroimmunology, 158 (1-2), 67-75. doi:10.1016/j.jneuroim.2004.08.007

Geenen, V., Louis, C., & Martens, H. (December 2004). An insulin-like growth factor 2-derived self-antigen inducing a regulatory cytokine profile after presentation to peripheral blood mononuclear cells from DQ8(+) type 1 diabetic adolescents - Preliminary design of a thymus-based tolerogenic self-vaccination. Annals of the New York Academy of Sciences, 1037, 59-64. doi:10.1196/annals.1337.008

Pequeux, C., Keegan, B. P., Hagelstein, M. T., Geenen, V., Legros, J.-J., & North, W. G. (December 2004). Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway. Endocrine-Related Cancer, 11 (4), 871-885. doi:10.1677/erc.1.00803

PERRIER d'HAUTERIVE, S., Charlet-Renard, J. D. C., Berndt, S., Dubois, M., Munaut, C., Goffin, F., Hagelstein, M.-T., Noël, A., Hazout, Foidart, J.-M., & Geenen, V. (November 2004). Human chorionic gonadotropin and growth factors at the embryonic-endometrial interface control leukemia inhibitory factor (LIF) and interleukin 6 (IL-6) secretion by human endometrial epithelium. Human Reproduction, 19 (11), 2633-2643. doi:10.1093/humrep/deh450

Hansenne, I., Rasier, G., Charlet-Renard, C., Defresne, M.-P., Greimers, R., Breton, C., Legros, J.-J., Geenen, V., & Martens, H. (March 2004). Neurohypophysial Receptor Gene Expression by Thymic T Cell Subsets and Thymic T Cell Lymphoma Cell Lines. Clinical and Developmental Immunology, 11 (1), 45-51. doi:10.1080/10446670410001670481

Brilot, F., Geenen, V., Hober, D., & Stoddart, C. (2004). Coxsackievirus B4 infection of human fetal thymus cells. Journal of Virology, 78 (18), 9854-9861. doi:10.1128/JVI.78.18.9854-9861.2004

Geenen, V. (2004). Nouvelles approches du diagnostic et de la pathogénie du diabète de type 1. Louvain Medical, 123, 253-259.

Geenen, V., Brilot, F., Hansenne, I., Louis, C., & Martens, H. (2004). Presentation of neuroendocrine self in the thymus: toward a novel type of vaccine/immunotherapy. Drug Design Reviews - Online, 1, 37-42.

Geenen, V., Brilot, F., Hansenne, I., Renard, C., & Martens, H. (2004). Thymus and T cells. In B. H. Smith & G. Adelman (Eds.), Encyclopedia of Neuroscience, 3rd Edition. New York, United States: Elsevier Science.

Geenen, V., & Brilot, F. (May 2003). Role of the thymus in the development of tolerance and autoimmunity towards the neuroendocrine system. Annals of the New York Academy of Sciences, 992, 186-195. doi:10.1111/j.1749-6632.2003.tb03149.x

Brilot, F., & Geenen, V. (2003). Virus infections in pathogenesis of type 1 diabetes. International Diabetes Monitor, 14, 21-24.

Geenen, V. (2003). The thymic insulin-like growth factor axis: Involvement in physiology and disease. Hormone and Metabolic Research, 35 (11-12, Nov-Dec), 656-663. doi:10.1055/s-2004-814161

Pequeux, C., Keegan, B. P., Hagelstein, M.-T., Geenen, V., North, W. G., & Legros, J.-J. (2003). Oxytocin and vasopressin autocrine/paracrine signaling in small cell lung carcinoma. International Journal of Molecular Medicine, 12/S1, 72.

Perrier D'Hauterive, S., Charlet-Renard, J. D. C., Goffin, F., Foidart, J.-M., & Geenen, V. (September 2002). La fenetre implantatoire. Journal de Gynécologie, Obstétrique et Biologie de la Reproduction, 31 (5), 440-55.

Pequeux, C., Breton, C., Hendrick, J.-C., Hagelstein, M.-T., Martens, H., Winkler, R., Geenen, V., & Legros, J.-J. (15 August 2002). Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling. Cancer Research, 62 (16), 4623-4629.

Brilot, F., Chehadeh, W., Charlet-Renard, C., Martens, H., Geenen, V., & Hober, D. (May 2002). Persistent infection of human thymic epithelial cells by coxsackievirus B4. Journal of Virology, 76 (10), 5260-5265. doi:10.1128/JVI.76.10.5260-5265.2002

Franchimont, D., Galon, J., Vacchio, M. S., Fan, S., Visconti, R., Frucht, D. R., Geenen, V., Chrousos, G. P., Ashwell, J. D., & O'Shea, J. J. (2002). Positive effects of glucocorticoids on T cell function by upregulation of interleukin-7 receptor alpha. Journal of Immunology, 168, 2212-2218.

Geenen, V. (2002). Thymus, central T cell self-tolerance and type 1 diabetes. International Diabetes Monitor, 14, 15-18.

Geenen, V. (2001). Absence of protective effect of oral insulin on residual ß-cell function in type 1 diabetes. International Diabetes Monitor, 13, 17-19.

Geenen, V., Kecha, O., Brilot, F., Hansenne, I., Renard, C., & Martens, H. (2001). Thymic T-cell tolerance of neuroendocrine functions: physiology and pathophysiology. In Y. Kinoshita & K.-J. Halbhuber (Eds.), Recent Advances in the Immunobiology of the Thymus (pp. 179-188). Noisy-le Grand, France: CMB Association.

Geenen, V., Martens, H., Hansenne, I., Brilot, F., & Kecha, O. (2001). Central self-tolerance by thymic presentation of self-antigens and autoimmunity. Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents, 1, 47-60.

Kecha-Kamoun, O., Achour, I., Martens, H., Collette, J., Lefebvre, P. J., Greiner, D. L., & Geenen, V. (2001). Thymic Expression of Insulin-Related Genes in an Animal Model of Autoimmune Type 1 Diabetes. Diabetes/Metabolism Research and Reviews, 17 (2, Mar-Apr), 146-52. doi:10.1002/dmrr.182

Pequeux, C., Hendrick, J.-C., Hagelstein, M.-T., Geenen, V., & Legros, J.-J. (2001). Novel plasma extraction procedure and development of a specific enzyme immunoassay of oxytocin: application to biological and clinical investigations of small-cell carcinoma of the lung. Scandinavian Journal of Clinical and Laboratory Investigation, 61 (5), 407-415. doi:10.1080/003655101316911468

Kecha, O., Brilot, F., Martens, H., Franchimont, N., Renard, C., Greimers, R., Defresne, M.-P., Winkler, R., & Geenen, V. (March 2000). Involvement of Insulin-Like Growth Factors in Early T Cell Development: A Study Using Fetal Thymic Organ Cultures. Endocrinology, 141 (3), 1209-17. doi:10.1210/endo.141.3.7360

Geenen, V., Martens, H., Brilot, F., Renard, C., Franchimont, D., & Kecha, O. (2000). Thymic neuroendocrine self-antigens. Role in T-cell development and central T-cell self-tolerance. Annals of the New York Academy of Sciences, 917, 710-723. doi:10.1111/j.1749-6632.2000.tb05435.x

Franchimont, D., Martens, H., Hagelstein, M.-T., Louis, E., Dewé, W., Chrousos, G. P., Belaiche, J., & Geenen, V. (August 1999). Tumor Necrosis Factor Alpha Decreases, and Interleukin-10 Increases, the Sensitivity of Human Monocytes to Dexamethasone: Potential Regulation of the Glucocorticoid Receptor. Journal of Clinical Endocrinology and Metabolism, 84 (8), 2834-9. doi:10.1210/jcem.84.8.5931

Kecha, O., Martens, H., Franchimont, N., Achour, I., Hazee-Hagelstein, M.-T., Charlet-Renard, C., Geenen, V., & Winkler, R. (June 1999). Characterization of the Insulin-Like Growth Factor Axis in the Human Thymus. Journal of Neuroendocrinology, 11 (6), 435-40. doi:10.1046/j.1365-2826.1999.00343.x

Franchimont, D., Louis, E., Dupont, P., Vrindts-Gevaert, Y., Dewé, W., Chrousos, G., Geenen, V., & Belaiche, J. (1999). Decreased Corticosensitivity in Quiescent Crohn's Disease: An Ex Vivo Study Using Whole Blood Cell Cultures. Digestive Diseases and Sciences, 44 (6), 1208-15. doi:10.1023/A:1026644711530

Geenen, V., Kecha, O., Brilot, F., Renard, C., & Martens, H. (1999). The thymic repertoire of neuroendocrine-related self-antigens: Biological role in T-cell selection and pharmacological implications. In W. Savino (Ed.), Neuroendocrine Control of the Thymus (pp. 115-125). Basel, Switzerland: Karger. doi:10.1159/000026371

Geenen, V., Wiemann, M., & Martens, H. (1999). Thymus gland, Neuroendocrine-Immunology. In G. Adelman & B. H. Smith (Eds.), Encyclopedia of Neuroscience, 2nd enlarged and revised edition (pp. 2039-2042). New York, United States: Elsevier Science.

Geenen, V., & Lefebvre, P. J. (March 1998). The Intrathymic Expression of Insulin-Related Genes: Implications for Pathophysiology and Prevention of Type 1 Diabetes. Diabetes/Metabolism Reviews, 14 (1), 95-103. doi:10.1002/(SICI)1099-0895(199803)14:1<95::AID-DMR200>3.0.CO;2-W

Franchimont, D., Louis, E., Dewé, W., Martens, H., Vrindts-Gevaert, Y., De Groote, D., Belaiche, J., & Geenen, V. (02 January 1998). Effects of Dexamethasone on the Profile of Cytokine Secretion in Human Whole Blood Cell Cultures. Regulatory Peptides, 73 (1), 59-65. doi:10.1016/S0167-0115(97)01063-X

Geenen, V., Kecha, O., & Martens, H. (1998). Thymic expression of neuroendocrine self-peptide precursors: role in T-cell survival and self-tolerance. Journal of Neuroendocrinology, 10, 811-822. doi:10.1046/j.1365-2826.1998.00269.x

Martens, H., Kecha, O., Charlet-Renard, J. D. C., Defresne, M.-P., & Geenen, V. (1998). Neurohypophysial peptides stimulate the phosphorylation of pre-T cell focal adhesion kinases. Neuroendocrinology, 67 (4), 282-289. doi:10.1159/000054324

Louis, E., Belaiche, J., Van Kemseke, C., Franchimont, D., de Groote, D., Geenen, V., & Mary, J. Y. (October 1997). A High Serum Concentration of Interleukin-6 Is Predictive of Relapse in Quiescent Crohn's Disease. European Journal of Gastroenterology and Hepatology, 9 (10), 939-44. doi:10.1097/00042737-199710000-00004

Vanneste, Y., Ntodou-Thomé, A., Vandersmissen, E., Charlet-Renard, J. D. C., Franchimont, D., Martens, H., Lhiaubet, A.-M., Schimpff, R.-M., Rostène, W., & Geenen, V. (1997). Identification of neurotensin-related peptides in human thymic epithelial cell membranes and relationship with MHC class I molecules. Journal of Neuroimmunology, 76, 161-166. doi:10.1016/S0165-5728(97)00052-0

Martens, H., Malgrange, B., Robert, F., Charlet, C., De Groote, D., Heymann, D., Godard, A., Soulillou, J. P., Moonen, G., & Geenen, V. (14 November 1996). Cytokine Production by Human Thymic Epithelial Cells: Control by the Immune Recognition of the Neurohypophysial Self-Antigen. Regulatory Peptides, 67 (1), 39-45. doi:10.1016/S0167-0115(96)00105-X

Martens, H., Goxe, B., & Geenen, V. (July 1996). The Thymic Repertoire of Neuroendocrine Self-Antigens: Physiological Implications in T-Cell Life and Death. Immunology Today, 17 (7), 312-7. doi:10.1016/0167-5699(96)10023-2

Lambrigts, D., Franssen, C., Martens, H., Van Calster, P., Meurisse, M., Geenen, V., Renard, C., Dewaele, A., Coignoul, F., Lamy, M., & Alexandre, G. P. J. (1996). Development of thymus autografts under the kidney capsule in the pig: a new 'organ' for xenotransplantation. Xenotransplantation, 3, 296-303. doi:10.1111/j.1399-3089.1996.tb00151.x

Geenen, V., Goxe, B., Martens, H., Vandersmissen, E., Vanneste, Y., Achour, I., Kecha, O., & Lefebvre, P. (1995). Cryptocrine Signaling in the Thymus Network and T Cell Education to Neuroendocrine Self-Antigens. Journal of Molecular Medicine, 73 (9), 449-55. doi:10.1007/BF00202263

Geenen, V., Martens, H., Kecha, O., Achour, I., Lefebvre, P., Franchimont, P., & Goxe, B. (1994). Les choix stratégiques actuels dans la prévention du processus diabétogène auto-immun. Médecine et Hygiène, 52, 1655-1658.

Geenen, V., Achour, I., Robert, F., Vandersmissen, E., Sodoyez, J.-C., Defresne, M.-P., Boniver, J., Lefebvre, P., & Franchimont, P. (1993). Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. Thymus, 21 (2), 115-127.

Geenen, V., & Kroemer, G. (1993). The multiple ways to cellular immunological tolerance. Immunology Today, 14, 573-576. doi:10.1016/0167-5699(93)90195-Q

Geenen, V., Robert, F., Martens, H., De Groote, D., & Franchimont, P. (1992). The thymic education of developing T cells in self neuroendocrine principles. Journal of Endocrinological Investigation, 15, 621-629. doi:10.1007/BF03344936

Legros, J.-J., Geenen, V., Gazzotti, C., Timsit-Berthier, M., & ANSSEAU, M. (1992). Peptides neurohypophysaires et psychopathologie. Revue Française d'Endocrinologie Clinique, Nutrition, et Métabolisme, 33 (2), 115-120.

Robert, F. R., Martens, H., Cormann, N., Benhida, A., Schoenen, J., & Geenen, V. (1992). The Recognition of Hypothalamo-Neurohypophysial Functions by Developing T Cells. Developmental Immunology, 2 (2), 131-40. doi:10.1155/1992/98671

Ericsson, A., Geenen, V., Robert, F., Legros, J.-J., Vrindts-Gevaert, Y., Franchimont, P., Brene, S., & Persson, H. (1990). Expression of preprotachykinin-A and neuropeptide-Y messenger RNA in the thymus. Molecular Endocrinology, 4, 1211-1218. doi:10.1210/mend-4-8-1211

Ansseau, M., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Timsit-Berthier, M., Geenen, V., & Legros, J.-J. (1988). Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. British Journal of Psychiatry, 153 (1), 65-71. doi:10.1192/bjp.153.1.65

Geenen, V., Adam, F., Baro, V., Mantanus, H., Ansseau, M., Timsit-Berthier, M., & Legros, J.-J. (1988). Inhibitory influence of oxytocin infusion on contingent negative variation and some memory tasks in normal men. Psychoneuroendocrinology, 13 (5), 367-375. doi:10.1016/0306-4530(88)90043-1

Honore, P., Meurisse, M., Jacquet, N., Defraigne, J.-O., Larbuisson, R., Cayet-Honore, A.-M., Stockman, D., Canivet, J.-L., Damas, P., Philippart, C., Geenen, V., Schurgers, P., Pirotte, J., Mazy, V., Beaujean, A.-M., Beaumariage, M.-L., Henrivaux, P., & Bury, J. (1988). Un cas de maladie métabolique hépatique de Wilson traité radicalement par une transplantation de foie. Revue Médicale de Liège, 43, 526-529.

Ansseau, M., Legros, J.-J., Mormont, C., Cerfontaine, J.-L., Papart, P., Geenen, V., & Franck, G. (1987). Intranasal oxytocin in obsessive-compulsive disorder. Psychoneuroendocrinology, 12, 231-236. doi:10.1016/0306-4530(87)90009-6

Ansseau, M., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Timsit-Berthier, M., Geenen, V., & Legros, J.-J. (1987). Neuroendocrine evaluation of catecholaminergic neurotransmission in mania. Psychiatry Research, 22 (3), 193-206. doi:10.1016/0165-1781(87)90034-5

Demey-Ponsart, E., Ansseau, M., Sulon, J., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Geenen, V., & Legros, J.-J. (1987). Diagnostic performance of basal free cortisol/18-hydroxy-11-deoxy-corticosterone (18-OH-DOC) ratio in endogenous depression: comparison with the dexamethasone suppression test. Biological Psychiatry, 22 (8), 947-956. doi:10.1016/0006-3223(87)90004-7

Legros, J.-J., Geenen, V., & Ansseau, M. (1987). Le point actuel sur l'utilisation de la vasopressine et de l'ocytocine en psychiatrie. Médecine et Hygiène, 45, 2169-2177.

Ansseau, M., Geenen, V., Franck, G., & Legros, J.-J. (1986). Dexamethasone suppression test and MMPI scales. Neuropsychobiology, 16 (2-3), 68-71. doi:10.1159/000118300

Ansseau, M., von Frenckell, R., Franck, G., Timsit-Berthier, M., Geenen, V., & Legros, J.-J. (1986). Blunted growth hormone response to clonidine and apomorphine challenges in endogenous depression. In C. Shagass (Ed.), Biological psychiatry : proceedings of the IVth world congress of biological psychiatry, September 8th through 13th, 1985 in Philadelphia (pp. 793-795). New York, United States: Elsevier.

Geenen, V., Legros, J.-J., Franchimont, P., Baudrihaye, M., Defresne, M.-P., & Boniver, J. (1986). The neuroendocrine thymus: Coexistence of oxytocin and neurophysin in the human thymus. Science, 232, 508-511. doi:10.1126/science.3961493

Timsit-Berthier, M., Mantanus, H., Marissiaux, P., Ansseau, M., Doumont, A., Geenen, V., & Legros, J.-J. (1986). CNV and dopamine receptor reactivity: correlations with the apomorphine test. In W. C. McCallum (Ed.), Cerebral psychophysiology: Studies in event-related potentials (pp. 403-405). New York, United States: Elsevier.

Ansseau, M., Doumont, A., Cerfontaine, J.-L., Sulon, J., Demey-Ponsart, E., Geenen, V., & Legros, J.-J. (1985). Diagnostic performance of the thirty-four hour dexamethasone suppression test. Psychoneuroendocrinology, 10, 215-219. doi:10.1016/0306-4530(85)90060-5

Ansseau, M., Reynolds, C. F. I., Kupfer, D., Doumont, A., Geenen, V., Dresse, A., & Juorio, A. (1985). Extrapyramidal signs following zimelidine overdose. Journal of Clinical Psychopharmacology, 5 (6), 347-348. doi:10.1097/00004714-198512000-00010

Geenen, V., Langer, G., Koïnig, G., Schönbeck, G., Ansseau, M., von Frenckell, R., & Legros, J.-J. (1985). Release of human neurophysin I during insulin-induced hypoglycemia is abolished after recovery with clomipramine treatment. Psychoneuroendocrinology, 10 (1), 61-69. doi:10.1016/0306-4530(85)90039-3

Geenen, V., Legros, J.-J., Hagelstein, M.-T., Louis-Kohn, F., Lecomte-Yerna, M.-J., Demoulin, A., & Franchimont, P. (1985). Release of immunoreactive oxytocin and neurophysin I by cultured luteinizing bovine granulosa cells. Acta Endocrinologica, 110, 263-270. doi:10.1530/acta.0.1100263

Ansseau, M., Doumont, A., Thiry, D., Geenen, V., & Legros, J.-J. (1983). Interest of 5-hydroxytryptophan (5-HTP) test as a neuroendocrine marker of depressive illness. Acta Psychiatrica Belgica, 83 (1), 50-56.

Legros, J.-J., Ansseau, M., Doumont, A., Geenen, V., & van Wimersma-Greidanus, T. (1983). Relationship between vasopressin, neurophysin and ACTH, cortisol plasma levels in non suppressor patients during dexamethasone suppression tests. Neuro Endocrinology Letters, 5 (5), 297-302.